A new study reveals promising results for a vaccine targeting colorectal and pancreatic cancers. Researchers from the ...

Public awareness about the link between human papillomavirus, or HPV, and cancer is low. A doctor explains why its lifesaving ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

An 'off-the-shelf' vaccine may help prevent or delay cancer recurrence in people with hard-to-treat colorectal or pancreatic ...

An off-the-shelf cancer vaccine that targets KRAS mutations induced T-cell responses and was associated with impressive ...

IO Biotech plans to meet with the FDA this fall to discuss the data from the phase 3 trial of Cylembio and determine next ...

New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.

Scripps News speaks with vaccine experts who say HHS funding cuts targeting mRNA vaccines could hinder other vaccine research ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

Cancer vaccines in development rely on mRNA technology under attack by RFK Jr. “I am concerned that this could bleed over," ...

The vaccine used in this trial, known as AHEAD-MERIT (BNT113-01), will help the immune system recognise and kill cancer cells ...

A new mRNA-based vaccine triggers a response from the innate immune system to help arm the body against cancer, a mouse study ...